I

Ipsen Global

Global biopharma focused on specialty care

VP Global Asset Lead

Biology & BiotechConfirmed live in the last 24 hours
Full-timeNo salary listed

About the Job

Requirements

  • Senior global pharmaceutical leader with strong experience in asset leadership, late-stage development, commercial strategy, or global launch preparation.
  • Proven ability to lead a complex asset from development through investment decision-making, launch planning, and value capture.
  • Strong experience in the United States pharmaceutical market, including payer access, provider economics, health care professional segmentation, forecasting, launch investment, and competitive strategy.
  • Strong understanding of how clinical development, regulatory strategy, evidence generation, payer value, medical strategy, and commercial execution interact.
  • Experience making prioritization decisions across indications, markets, and development options.
  • Demonstrated success leading cross-functional teams in a matrix without relying only on direct authority.
  • Ability to challenge assumptions, pressure-test forecasts, and translate uncertainty into clear executive choices.
  • An advanced degree in Life Sciences, Business, or a related field is essential.
  • English is essential; other languages are an advantage.

Responsibilities

  • Own the global Corabotase Tx strategy and value-creation plan across priority therapeutic indications.
  • Define Corabotase's role within the broader Neuroscience franchise, including its relationship with Dysport and future portfolio opportunities.
  • Translate the asset ambition into enterprise choices on indication prioritization, development sequencing, investment allocation, and launch readiness.
  • Lead the integrated development strategy from proof of concept through pivotal development, filing, and launch preparation.
  • Define indication-specific development pathways, investment requirements, probability of success, and value-creation opportunities.
  • Deliver decision-ready recommendations and governance materials for PFR, senior leadership, and Board review.
  • Own indication prioritization and sequencing across therapeutic opportunities to maximize long-term enterprise value.
  • Define differentiated value propositions grounded in patient needs, customer insights, market dynamics, and access realities.
  • Ensure strategic choices are based on realistic value capture and competitive advantage rather than theoretical market potential alone.
  • Lead long-range forecasting, commercial strategy, and launch-readiness planning across priority markets.
  • Define realistic value-capture scenarios and the capabilities, investments, and partnerships required to deliver them.
  • Ensure commercial strategies are grounded in robust customer, payer, provider, and competitive insights.
  • Optimize portfolio value by managing interactions, synergies, and resource allocation across Dysport, Corabotase Tx, and Corabotase Ax.
  • Define franchise strategies that maximize overall value creation while managing cannibalization and lifecycle opportunities.
  • Lead scenario planning around pricing, access, competitive dynamics, and portfolio evolution.
  • Lead and integrate a high-performing cross-functional Global Asset Team aligned around common objectives and priorities.
  • Establish effective governance, decision rights, escalation pathways, and performance-management processes.
  • Bring concise, data-driven, decision-ready recommendations to senior leadership and governance forums.
  • Own the Corabotase Tx investment plan, budget, and resource allocation across the asset lifecycle.
  • Ensure investment decisions are linked to value creation, risk reduction, and strategic priorities.
  • Partner with Finance to monitor performance, optimize resource deployment, and support key investment decisions.
  • Complete all activities in compliance with Ipsen policies, research and development standard operating procedures, Good Clinical Practice, and relevant national and international regulations.

Desired Qualifications

  • An MBA or equivalent business qualification is a plus.
  • Other languages are an advantage.

About the Company

Ipsen Global

Global biopharma focused on specialty care

Ipsen is a global biopharmaceutical company that concentrates on specialty care, developing and marketing medicines for oncology, neuroscience, and rare diseases. Its products work by treating specific high-need conditions, ranging from historical diarrhea treatment Smecta to modern targeted therapies in cancer and neurological disorders. The company differentiates itself through a focused portfolio in niche therapeutic areas, growth via strategic acquisitions, and a long-standing family heritage that shaped its international expansion and IPO-driven capital for expansion. Its goal is to address unmet medical needs worldwide by providing effective therapies for patients with serious or rare conditions.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boulogne-Billancourt, France
Founded
2005

Recently Posted Jobs

Explore more opportunities at Ipsen Global

See more jobs